[Form 4] WORTHINGTON ENTERPRISES, INC. Insider Trading Activity

Rhea-AI Filing Summary

Worthington Enterprises director John B. Blystone received a restricted stock award of 4,035 common shares under the Worthington Enterprises, Inc. 2025 Equity Plan for Non-Employee Directors. The award was granted on 09/25/2025 and will vest on the earlier of the first anniversary of the grant date or the date of the next Annual Meeting of Shareholders. Following the grant, Mr. Blystone beneficially owns 173,010 shares. The grant was reported on Form 4 and signed on 09/26/2025 by an attorney-in-fact.

Positive

• Restricted stock grant of 4,035 shares awarded to director John B. Blystone on 09/25/2025
• Post-grant beneficial ownership reported as 173,010 common shares

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine director compensation via restricted stock aligns the director with shareholder interests and follows the company equity plan.

The Form 4 discloses a non-employee director award of 4,035 restricted common shares under the company's 2025 Equity Plan for Non-Employee Directors. Vesting is time- and event-based: earlier of one year from grant or the next annual shareholders meeting. This appears to be a standard director grant consistent with periodic equity compensation practices; it increases reported beneficial ownership to 173,010 shares. The filing format and signature by attorney-in-fact comply with Section 16 reporting requirements.

Securities Analyst

TL;DR: The transaction is a disclosed, non-cash equity grant that affects beneficial ownership totals but does not report any sale or purchase price.

The reported transaction code is 'A' (acquisition) for 4,035 shares at a $0.00 reported price, indicating a restricted stock grant rather than an open-market purchase. The disclosure includes the exact post-transaction beneficial ownership figure of 173,010 shares. No derivative securities or other transactions are reported on this Form 4. The filing provides clear, specific transaction and vesting details required for investor transparency.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

BLYSTONE JOHN B

(Last) (First) (Middle)

200 WEST OLD WILSON BRIDGE ROAD

(Street)

COLUMBUS OH 43085

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WORTHINGTON ENTERPRISES, INC. [ WOR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	09/25/2025		A		4,035(1)	A	$0.00	173,010	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. An award of restricted stock was granted pursuant to the Worthington Enterprises, Inc. 2025 Equity Plan for Non-Employee Directors. The restricted stock will vest on the earlier to occur of (1) the first anniversary of the grant date; or (2) the date on which the next Annual Meeting of Shareholders of Worthington Enterprises, Inc. is held.

	/s/Patrick J. Kennedy, as attorney-in-fact for John B. Blystone	09/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did John B. Blystone report on Form 4 for WOR?

He reported an acquisition of 4,035 restricted common shares under the 2025 Equity Plan for Non-Employee Directors, granted 09/25/2025.

When do the restricted shares vest?

The restricted shares vest on the earlier of (1) the first anniversary of the grant date or (2) the date of the next Annual Meeting of Shareholders.

How many shares does Mr. Blystone beneficially own after the grant?

He beneficially owns 173,010 common shares following the reported transaction.

Was any cash price reported for the acquisition?

The reported price is $0.00, indicating a grant of restricted stock rather than a market purchase.

Who signed the Form 4 and when was it filed?

The form was signed by Patrick J. Kennedy as attorney-in-fact for John B. Blystone and dated 09/26/2025.